Patent Assignment
Reel/Frame 055085/0660
Assignment of Assignor's Interest
Recorded: 2021-01-29
Pages: 3
Assignor
FUSION ANTIBODIES PLC.
Executed: 2020-12-07
Assignee
AMUNIX PHARMACEUTICALS, INC.
2 TOWER PLACE #1100, SOUTH SAN FRANCISCO, CALIFORNIA, 94080-1826
Covered Property
(1)
Egfr Antigen Binding Fragments and Compositions Comprising Same
PCT:
PCT/US2020/039682 ↗
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 29, 2021
From: MACCANN, DARRAGH; MCCLORY, JAMES
To: FUSION ANTIBODIES PLC.
Reel/Frame 055085/0657 →
Change of Name
Feb 4, 2021
From: AMUNIX OPERATING INC.
To: AMUNIX PHARMACEUTICALS, INC.
Reel/Frame 055223/0978 →
Assignment of Assignor's Interest
Jun 5, 2024
From: SCHELLENBERGER, VOLKER
To: AMUNIX PHARMACEUTICALS, INC.
Reel/Frame 067624/0024 →
Assignment of Assignor's Interest
Jun 5, 2024
From: FRENZEL, ANDRÉ; KUHN, PHILIPP
To: YUMAB GMBH
Reel/Frame 067624/0179 →
Assignment of Assignor's Interest
Jun 5, 2024
From: YUMAB GMBH
To: AMUNIX PHARMACEUTICALS, INC.
Reel/Frame 067624/0318 →
Assignment of Assignor's Interest
Jun 5, 2024
From: FUSION ANTIBODIES PLC
To: AMUNIX PHARMACEUTICALS, INC.
Reel/Frame 067624/0623 →